Takeda Pharmaceutical Co., Ltd. (TAK)
16.46
-0.18
(-1.08%)
USD |
NYSE |
May 08, 16:00
16.46
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Market Cap : 51.98B for May 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sanofi | 105.63B |
| Eli Lilly & Co. | 845.77B |
| Johnson & Johnson | 532.77B |
| AstraZeneca PLC | 283.57B |
| Novartis AG | 278.64B |
Market Cap Related Metrics
| PE Ratio | 68.36 |
| PS Ratio | 1.750 |
| Price to Book Value | 1.066 |
| Price to Free Cash Flow | 12.01 |
| Price | 16.46 |
| Earnings Yield | 1.46% |
| Operating PE Ratio | 14.85 |
| Normalized PE Ratio | 47.23 |